S Keith Anderson Selected Research

raf Kinases

1/2018

Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Keith Anderson Research Topics

Disease

19	Neoplasms (Cancer) 12/2022 - 01/2008
14	Glioblastoma (Glioblastoma Multiforme) 11/2023 - 02/2012
6	Brain Neoplasms (Brain Tumor) 12/2022 - 01/2010
5	Breast Neoplasms (Breast Cancer) 03/2015 - 12/2010
4	Prostatic Neoplasms (Prostate Cancer) 03/2011 - 01/2008
3	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2017
3	Glioma (Gliomas) 11/2019 - 12/2010
3	Disease Progression 01/2018 - 01/2008
2	Cognitive Dysfunction 01/2023 - 07/2016
1	Oligodendroglioma 01/2021
1	Necrosis 01/2021
1	Measles 01/2021
1	Infections 10/2018
1	Hematologic Neoplasms (Hematological Malignancy) 10/2018
1	Neutropenia 01/2018
1	Hyperglycemia 01/2018
1	Fatigue 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2017
1	Brain Diseases (Brain Disorder) 01/2017
1	Astrocytoma (Pilocytic Astrocytoma) 12/2015
1	Hypoxia (Hypoxemia) 09/2013
1	Osteosarcoma (Osteogenic Sarcoma) 12/2010
1	Leukemia 12/2010
1	Seizures (Absence Seizure) 12/2010

Drug/Important Bio-Agent (IBA)

7	Temozolomide (Temodar)FDA LinkGeneric 11/2023 - 06/2013
5	Bevacizumab (Avastin)FDA Link 01/2022 - 09/2013
5	RNA (Ribonucleic Acid)IBA 10/2018 - 01/2008
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2008
3	Trastuzumab (Herceptin)FDA Link 03/2015 - 02/2011
3	ParaffinIBA 01/2013 - 01/2008
3	AndrogensIBA 03/2011 - 04/2009
2	AntigensIBA 01/2022 - 01/2021
2	Vorinostat FDA Link 01/2018 - 02/2012
2	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 09/2013
2	Formaldehyde (Formol)FDA Link 01/2013 - 12/2010
2	Androgen Receptors (Androgen Receptor)IBA 03/2011 - 12/2009
2	human ERBB2 proteinIBA 02/2011 - 12/2010
1	EnzymesIBA 01/2023
1	ImmunosorbentsIBA 01/2023
1	VaccinesIBA 01/2022
1	carotuximabIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Bacterial AntigensIBA 01/2021
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2021
1	Dasatinib (BMS 354825)FDA Link 11/2019
1	src-Family KinasesIBA 11/2019
1	Janus Kinase InhibitorsIBA 10/2018
1	ruxolitinibIBA 10/2018
1	InterferonsIBA 10/2018
1	raf KinasesIBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	temsirolimus FDA Link 01/2018
1	Everolimus FDA Link 09/2015
1	ErbB Receptors (EGF Receptor)IBA 03/2015
1	Messenger RNA (mRNA)IBA 03/2015
1	Therapeutic UsesIBA 09/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2013
1	Complementary DNA (cDNA)IBA 01/2013
1	Recombinant DNA (Recombinant DNA Research)IBA 01/2013
1	Lapatinib (GW572016)FDA Link 01/2013
1	IntegrinsIBA 01/2013
1	Proteasome InhibitorsIBA 02/2012
1	Histone Deacetylases (Histone Deacetylase)IBA 02/2012
1	Bortezomib (Velcade)FDA Link 02/2012
1	Histone Deacetylase InhibitorsIBA 02/2012
1	Cyclin A2IBA 12/2010
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 12/2010
1	Proteins (Proteins, Gene)FDA Link 12/2010
1	Estrogen ReceptorsIBA 12/2010
1	SurvivinIBA 12/2010
1	Wnt-5a ProteinIBA 12/2010
1	GRB7 Adaptor ProteinIBA 12/2010
1	Levetiracetam (Keppra)FDA LinkGeneric 12/2010
1	Phenytoin (Dilantin)FDA LinkGeneric 12/2010
1	Anticonvulsants (Antiepileptic Drugs)IBA 12/2010
1	Cholestenone 5 alpha-Reductase (5 alpha-Reductase)IBA 12/2009
1	Dutasteride (Avodart)FDA Link 12/2009
1	LigandsIBA 12/2009
1	5-alpha Reductase InhibitorsIBA 12/2009

Therapy/Procedure

12	Radiotherapy 01/2023 - 09/2015
7	Therapeutics 12/2022 - 01/2008
2	Drug Therapy (Chemotherapy) 01/2018 - 06/2013
1	Conformal Radiotherapy 11/2023
1	Chemoradiotherapy 11/2023
1	Immunotherapy 01/2021
1	Contraindications 01/2021
1	Oncolytic Virotherapy 10/2018
1	Cognitive Training 03/2015
1	Combination Drug Therapy (Combination Chemotherapy) 03/2015
1	Ligation 01/2013
1	Chemoprevention 12/2009
1	Prostatectomy (Retropubic Prostatectomy) 01/2008